224 related articles for article (PubMed ID: 32457900)
1. An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.
Quan MY; Guo Q; Liu J; Yang R; Bai J; Wang W; Cai Y; Han R; Lv YQ; Ding L; Billadeau DD; Lou Z; Bellusci S; Li X; Zhang JS
Front Cell Dev Biol; 2020; 8():287. PubMed ID: 32457900
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
3. AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.
Aytatli A; Barlak N; Sanli F; Caglar HO; Gundogdu B; Tatar A; Ittmann M; Karatas OF
Cell Oncol (Dordr); 2022 Feb; 45(1):41-56. PubMed ID: 34837170
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.
Quan MY; Guo Q; Liu J; Yang R; Bai J; Wang W; Cai Y; Han R; Lv YQ; Ding L; Billadeau DD; Lou Z; Bellusci S; Li X; Zhang JS
Front Cell Dev Biol; 2020; 8():594589. PubMed ID: 33117821
[TBL] [Abstract][Full Text] [Related]
5. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract][Full Text] [Related]
6. FGF receptors: cancer biology and therapeutics.
Katoh M; Nakagama H
Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
[TBL] [Abstract][Full Text] [Related]
7. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
[TBL] [Abstract][Full Text] [Related]
8. IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells.
Kornmann M; Ishiwata T; Matsuda K; Lopez ME; Fukahi K; Asano G; Beger HG; Korc M
Gastroenterology; 2002 Jul; 123(1):301-13. PubMed ID: 12105858
[TBL] [Abstract][Full Text] [Related]
9. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M
Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155
[TBL] [Abstract][Full Text] [Related]
11. Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.
Kornmann M; Lopez ME; Beger HG; Korc M
Int J Pancreatol; 2001; 29(2):85-92. PubMed ID: 11876253
[TBL] [Abstract][Full Text] [Related]
12. Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo.
Wagner M; Lopez ME; Cahn M; Korc M
Gastroenterology; 1998 Apr; 114(4):798-807. PubMed ID: 9516401
[TBL] [Abstract][Full Text] [Related]
13. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
16. FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium.
Cardoso WV; Itoh A; Nogawa H; Mason I; Brody JS
Dev Dyn; 1997 Mar; 208(3):398-405. PubMed ID: 9056643
[TBL] [Abstract][Full Text] [Related]
17. FGF and FGFR signaling in chondrodysplasias and craniosynostosis.
Marie PJ; Coffin JD; Hurley MM
J Cell Biochem; 2005 Dec; 96(5):888-96. PubMed ID: 16149058
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib suppresses fibroblast growth factor-2 expression in pancreatic ductal adenocarcinoma PANC-1 cells.
Li J; Luo M; Wang Y; Shang B; Dong L
Oncol Rep; 2016 Sep; 36(3):1345-52. PubMed ID: 27430377
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
Presta M; Chiodelli P; Giacomini A; Rusnati M; Ronca R
Pharmacol Ther; 2017 Nov; 179():171-187. PubMed ID: 28564583
[TBL] [Abstract][Full Text] [Related]
20. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
